Business Acquisition - Narratives (Details) - Nexus Medical Inc - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Sep. 11, 2025 |
Mar. 31, 2026 |
|
| Business Combination [Line Items] | ||
| Consideration transferred | $ 27.0 | |
| Contingent consideration related to acquisition | $ 20.0 | |
| Net sales | $ 5.8 | |
| Business acquisition, transaction costs | $ 0.9 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of acquiree's revenue since acquisition date of business combination included in consolidated statement of income. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|